References
- Agid Y., Jovoy-Agid F. Peptides and Parkinson's Disease. Trends in Neurological Sciences 1985; 8: 30–36
- Barden N., Dupont A., Labrie F., Merand Y., Rouleau D., Vaudry H., Boissier J. R. Age-dependent changes in the beta-endorphin content of discrete rat brain nuclei. Brain Research 1981; 208: 209–212
- Boller P., Mizutani T., Roessmann U., Gambette P. Parkinson's disease, dementia, and Alzheimer disease: clinicopathological correlation. Annals of Neurology 1980; 7: 329–335
- Carpenter M. B. Human neuroanatomy. 7th edition. Williams and Wilkins Company, Baltimore 1976; 435–491
- Cuello A. C. Central distribution of opicid peptides. British Medical Bulletin 1983; 39: 11–16
- Den Hartog W. A., Bethlem J. The distribution of Lewy bodies in the central and autonomic nervous system in idiopathic paralysis agitans. Journal of Neurology, Neurosurgery, Psychiatry 1960; 23: 283–299
- Ehringer H., Hronykiewicz O. Verteilung von Noradrenalin and Dopamine in Gehirn des Menschen und ihr Verhalten bei Erkranl ungen des extrapyramidalen Systems. Klinische Wochenschrift 1960; 38: 1236–1244
- Friedman E., Friedman J, Gershon S. Dopamine synthesis; stimulation by a hypothalamic factor. Science 1973; 182: 337–838
- Hirano A., Zimmerman H. M. Alzheimer's neurofibrillary changes. A topographic study. Archives of Neurology 1962; 7: 227–242
- Hokfelt T., Phillipson O., Goldstein M. Evidence for a dopaminergic pathway in the rat descending from the A II cell group to the spinal cord. Acta Physiology Scandinavia 1979; 10: 393–395
- Hornykiewicz O. Brain neurotransmitter changes in Parkinson's disease. Movement Disorders, C. D. Marsden, S. Fahn. Butterworths, London 1982
- Kaiya H., Tanaka T., Takeuchi K., Morita K., Adachi S., Shirakawa H., Ueki H., Namba M. Decreased level of beta-endorphin-like immunoreactivity in cerebrospinal fluid of patients with senile dementia of Alzheimer type. Life Sciences 1983; 33: 1039–1043
- Kievit J., Kuypers H. G. J. M. Basal forebrain and hypothalamic connections to frontal and parietal cortex in the rhesus monkey. Science 1975; 187: 660–661
- Langston J. W., Forno L. S. The hypothalamus in Parkinson's disease. Annals of Neurology 1978; 3: 129–133
- Lewy F. H. Die Lehre vom Tonus und der Bewegung. Springer., Berlin 1923
- Lloyd K., Hornykiewicz O. Parkinson's disease activity of L-dopa decarboxylase in discrete brain regions. Science 1970; 170: 1212–1213
- Marsden C. D. Basal-ganglia. Lancet 1982; 2: 1141–1146
- Matzuk M. M., Saper C. B. Preservation of hypothalamic dopaminergic neurons in Parkinson's disease. Annals of Neurology 1985; 18: 552–555
- Morley J. E. Neuropeptides, behavior and ageing. Journal of the American Geriatrics Society 1986; 34: 52–62
- Nappi G., Petraglia F., Martignoni E., Facehinetti F., Bono G., Genazzani A. R. Beta-endorphin cerebrospinal fluid decrease in untreated parkinsonian patients. Neurology 1985; 35: 1371–1374
- Rinne U. K. Neuroendocrine and extrapyramidal dopamine neurons in Parkinson's disease. Neuroendocrine Correlates in Neurology and Psychiatry, E. E. Miller, A. Agnoli. Elsevier-North Holland, Amsterdam 1979; 119–125
- Sandyk R. The endogenous opioid system in neurological disorders of the basal-ganglia. Life Sciences 1985; 37: 1655–1663
- Spencer S., Saper C. B., Joh T. H. Distribution of catecholamine-containing neurons in the normal human hypothalamus. Brain Research., (In press)
- Sulka R., Erkinjuntti T., Laatidainen T. CSF beta-endorphin and beta-lipotrophin in Alzheimer's disease and multi-infaret dementia. Neurology 1985; 35: 1057–1058
- Terry R. D., Davies P. Dementia of the Alzheimer type. Annual Reivew of Neuroscience 1980; 3: 77–95
- Von Buttlar-Brentano K. Zur Lebensgeschichte des Nucleus basalis, Tuberomammilaris, Supraopticus, und Paraventricularis unter normaien und pathogenen Bedingungen. Journal Hirnforsch 1954; 1: 337–419